As of 31 December 2006, Health Canada has received one more report of rosiglitazone-related parotid gland enlargement, taking the total to five

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1160, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic polymorphism behind rosiglitazone-related weight gain

By  

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Genetic polymorphism behind rosiglitazone-related weight gain

By  

Reactions Weekly, Vol. 1, Iss. 1112, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Health Canada has received four reports of Duragesic [fentanyl] patch abuse by boys aged 14-17 years, between 1 Jan 1998 and 31 Jan 2005

By  

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Ramipril: Parotid gland swelling: case report

By  

Reactions Weekly, Vol. 1, Iss. 1088, 2006-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

The Danish Health and Medicines Authority has received 31 reports of suspected adverse reactions in patients treated with strontium ranelate [Protelos].

By  

Reactions Weekly, Vol. 1, Iss. 1413, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite